MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Singh, Richa ^a   Yadav, Vikas ^a   Kumar, Sachin ^a   Saini, Neeru ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACACA PROTEIN, HUMAN; ACETYL COENZYME A CARBOXYLASE; CALCIDIOL 1 MONOOXYGENASE; CYP27B1 PROTEIN, HUMAN; FASN PROTEIN, HUMAN; FATTY ACID SYNTHASE; HMGCR PROTEIN, HUMAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MICRORNA; MIRN195 MICRORNA, HUMAN;

BREAST TUMOR; CELL MOTION; CELL PROLIFERATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIPID METABOLISM; METABOLISM; MITOCHONDRION; PATHOLOGY; TUMOR CELL LINE;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ACETYL-COA CARBOXYLASE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; FATTY ACID SYNTHASE, TYPE I; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; LIPID METABOLISM; MICRORNAS; MITOCHONDRIA;

EID: 84949294648     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17454     Document Type: Article

References (44)

1. Zhang, M. H., Man, H. T., Zhao, X. D., Dong, N. & Ma, S. L. Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials. Biomed Rep. 2, 41-52 (2014).
2. Zhang, Y., Su, H., Rahimi, M., Tochihara, R. & Tang, C. EGFRvIII-induced estrogen-independence, tamoxifen-resistance phenotype correlates with PgR expression and modulation of apoptotic molecules in breast cancer. Int J Cancer. 125, 2021-2028 (2009).
3. Currie, E., Schulze, A., Zechner, R., Walther, T. C. & Farese, R. V. Cellular fatty acid metabolism and cancer. Cell Metab. 18, 153-161 (2013).
4. Pizer, E. S. et al. Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells. Cancer Res. 56, 2745-2747 (1996).
5. Pizer, E. S. et al. Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. Cancer Res. 56, 1189-1193 (1996).
6. Zheng, L. et al. GDC-0941 sensitizes breast cancer to ABT-737 in vitro and in vivo through promoting the degradation of Mcl-1. Cancer Lett. 309, 27-36 (2011).
7. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell. 136, 215-233 (2009).
8. Garzon, R., Calin, G. A. & Croce, C. M. MicroRNAs in Cancer. Annu Rev Med. 60, 167-179 (2009).
9. Chen, Y. Q. et al. MicroRNA-195 promotes apoptosis in mouse podocytes via enhanced caspase activity driven by BCL2 insufficiency. Am J Nephrol. 34, 549-559 (2011).
10. Singh, R. & Saini, N. Downregulation of BCL2 by miRNAs augments drug-induced apoptosis - a combined computational and experimental approach. J Cell Sci. 125, 1568-1578 (2012).
11. Bhattacharya, A. et al. Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma. Oncogene. 32, 3175-3183 (2013).
12. Lin, Y. et al. Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells. FEBS Lett. 586, 442-447 (2012).
13. Xu, T. et al. MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology. 50, 113-121 (2009).
14. Yang, G. et al. Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1. Oncol Rep. 30, 877-889 (2013).
15. Schiemann, S., Schwirzke, M., Brünner, N. & Weidle, U. H. Molecular analysis of two mammary carcinoma cell lines at the transcriptional level as a model system for progression of breast cancer. Clin Exp Metastasis. 16, 129-39 (1998).
16. Kirschmann, D. A., Seftor, E. A., Nieva, D. R., Mariano, E. A. & Hendrix, M. J. Differentially expressed genes associated with the metastatic phenotype in breast cancer. Breast Cancer Res Treat. 55, 127-36 (1999).
17. Caton, P. W., Holness, M. J., Bishop-Bailey, D. & Sugden, M. C. PPARalpha-LXR as a novel metabolostatic signalling axis in skeletal muscle that acts to optimize substrate selection in response to nutrient status. Biochem J. 437, 521-530 (2011).
18. Kersten, S., Desvergne, B. & Wahli, W. Roles of PPARs in health and disease. Nature. 405, 421-424 (2000).
19. Lund, E. G., Menke, J. G. & Sparrow, C. P. Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis. Arterioscler Thromb Vasc Biol. 23, 1169-1177 (2003).
20. Horton, J. D. Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis. Biochem Soc Trans. 30, 1091-1095 (2002).
21. Fielding, C. J., Bist, A. & Fielding, P. E. Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Proc Natl Acad Sci USA. 94, 3753-3758 (1997).
22. Murata, M. et al. VIP21/caveolin is a cholesterol-binding protein. Proc Natl Acad Sci USA. 92, 10339-10343 (1995).
23. Ha, J. et al. Cloning of human acetyl-CoA carboxylase cDNA. Eur J Biochem. 219, 297-306 (1994).
24. Betel, D., Wilson, M., Gabow, A., Marks, D. S. & Sander, C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 36, D149-D153 (2008).
25. Kuhajda, F. P. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res. 66, 5977-5980 (2006).
26. Hunt, D. A., Lane, H. M., Zygmont, M. E., Dervan, P. A. & Hennigar, R. A. mRNA stability and overexpression of fatty acid synthase in human breast cancer cell lines. Anticancer Res. 27, 27-34 (2007).
27. Chajes, V., Cambot, M., Moreau, K., Lenoir, G. M. & Joulin, V. Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival. Cancer Res. 66, 5287-5294 (2006).
28. Oliveras, G. et al. Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2+ breast cancer. Ann NY Acad Sci. 1210, 86-92 (2010).
29. Orita, H., Coulter, J., Tully, E., Kuhajda, F. P. & Gabrielson, E. Inhibiting fatty acid synthase for chemoprevention of chemically induced lung tumors. Clin Cancer Res. 14, 2458-2464 (2008).
30. Sinilnikova, O. M. et al. Haplotype-based analysis of common variation in the acetyl-coA carboxylase alpha gene and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev. 16, 409-415 (2007).
31. Lee, J. S. et al. Fatty acid synthase inhibition by amentoflavone suppresses HER2/neu (erbB2) oncogene in SKBR3 human breast cancer cells. Phytother Res. 27, 713-720 (2013).
32. Mao, J. H. et al. microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN. Oncol Lett. 4, 1125-1129 (2012).
33. Bjarnadottir, O. et al. Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial. Breast Cancer Res Treat. 138, 499-508 (2013).
34. Clendening, J. W. & Penn, L. Z. Targeting tumor cell metabolism with statins. Oncogene. 31, 4967-4978 (2012).
35. Dunbar, D. R. et al. Transcriptional and physiological responses to chronic ACTH treatment by the mouse kidney. Physiol Genomics. 40, 158-166 (2010).
36. Lopes, N. et al. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions. BMC Cancer. 10, 483 (2010).
37. Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001).
38. Chhabra, R., Dubey, R. & Saini, N. Gene expression profiling indicate role of ER stress in miR-23a~27a~24-2 cluster induced apoptosis in HEK293T cells. RNA Biol. 8, 648-664 (2011).
39. Adlakha, Y. K. & Saini, N. miR-128 exerts pro-apoptotic effect in a p53 transcription-dependent and-independent manner via PUMA-Bak axis. Cell Death Dis. 4, e542 (2013).
40. Yadav, V., Varshney, P., Sultana, S., Yadav, J. & Saini,N. Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation. BMC Cancer. 15, 581 (2015).
41. Adlakha, Y. K. et al. Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRalpha expression and cholesterol homeostasis. Cell Death Dis. 4, e780 (2013).
42. Chowdhari, S. & Saini, N. hsa-miR-4516 mediated downregulation of STAT3/CDK6/UBE2N plays a role in PUVA induced apoptosis in keratinocytes. J Cell Physiol. 229, 1630-1638 (2014).
43. Yadav, V., Sultana, S., Yadav, J. & Saini, N. Gatifloxacin induces S and G2-phase cell cycle arrest in pancreatic cancer cells via p21/p27/p53. PLoS One. 7, e47796 (2012).
44. Goel, A. et al. DAMTC regulates cytoskeletal reorganization and cell motility in human lung adenocarcinoma cell line: an integrated proteomics and transcriptomics approach. Cell Death Dis. 3, e402 (2012).